- Home
- LIXT vs STSS Comparison
LIXT vs STSS Comparison
Compare LIXT & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- STSS
- Stock Information
- Founded
- LIXT 2005
- STSS 2017
- Country
- LIXT United States
- STSS United States
- Employees
- LIXT N/A
- STSS N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- LIXT Health Care
- STSS Health Care
- Exchange
- LIXT Nasdaq
- STSS Nasdaq
- Market Cap
- LIXT 4.1M
- STSS 4.6M
- IPO Year
- LIXT N/A
- STSS 2022
- Fundamental
- Price
- LIXT $2.33
- STSS $1.85
- Analyst Decision
- LIXT
- STSS
- Analyst Count
- LIXT 0
- STSS 0
- Target Price
- LIXT N/A
- STSS N/A
- AVG Volume (30 Days)
- LIXT 18.9K
- STSS 44.8K
- Earning Date
- LIXT 11-12-2024
- STSS 11-14-2024
- Dividend Yield
- LIXT N/A
- STSS N/A
- EPS Growth
- LIXT N/A
- STSS N/A
- EPS
- LIXT N/A
- STSS N/A
- Revenue
- LIXT N/A
- STSS N/A
- Revenue This Year
- LIXT N/A
- STSS N/A
- Revenue Next Year
- LIXT N/A
- STSS N/A
- P/E Ratio
- LIXT N/A
- STSS N/A
- Revenue Growth
- LIXT N/A
- STSS N/A
- 52 Week Low
- LIXT $1.31
- STSS $1.70
- 52 Week High
- LIXT $4.40
- STSS $18.15
- Technical
- Relative Strength Index (RSI)
- LIXT 54.46
- STSS 35.36
- Support Level
- LIXT $2.25
- STSS $1.79
- Resistance Level
- LIXT $2.68
- STSS $2.30
- Average True Range (ATR)
- LIXT 0.23
- STSS 0.13
- MACD
- LIXT 0.01
- STSS 0.01
- Stochastic Oscillator
- LIXT 53.90
- STSS 11.42
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.